DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Montalescot G, Zeymer U, Silvain J et al. ATOLL Investigators.
Intravenous enoxaparin or unfractionated heparin in primary percutaneous
coronary intervention for ST-elevation myocardial infarction: the international
randomised open-label ATOLL trial.
Lancet 2011;
378: 693-703
We do not assume any responsibility for the contents of the web pages of other providers.